106 STAT. 4528 PUBLIC LAW 102-573—OCT. 29, 1992

"(29) Reduce the maternal mortality rate to no more than
3.3 per 100,000 live births.

"(30) Reduce the incidence of fetal alcohol syndrome to
no more than 2 per 1,000 live births.

"(31) Reduce stroke deaths to no more than 20 per 100,000.

"(32) Reverse the increase in end-stage renal disease
(requiring maintenance dialysis or transplantation) to attain
an incidence of no more than 13 per 100,000.

"(33) Reduce breast cancer deaths to no more than 20.6
per 100,000 women.

"(34) Reduce deaths from cancer of the uterine cervix to
no more than 1.3 per 100,000 women.

"(35) Reduce colorectal cancer deaths to no more than
13.2 per 100,000.

(36) Reduce to no more than 11 percent the proportion
of individuals who experience a limitation in major activity
due to chronic conditions.

"(37) Reduce significant hearing impairment to a preva-
lence of no more than 82 per 1,000.

"(38) Reduce significant visual impairment to a prevalence
of no more than 30 per 1,000.

"(39) Reduce diabetes-related deaths to no more than 48
per 100,000.

"(40) Reduce diabetes to an incidence of no more than
2.5 per 1,000 and a prevalence of no more than 62 per 1,000.

"(41) Reduce the most severe complications of diabetes
as follows:

"(A) End-stage renal disease, 1.9 per 1,000.

"(B) Blindness, 1.4 per 1,000.

"(C) Lower extremity amputation, 4.9 per 1,000.

"(D) Perinatal mortality, 2 percent.

"(E) Major congenital malformations, 4 percent.

"(42) Confine annual incidence of diagnosed AIDS cases
to no more than 1,000 cases.

"(43) Confine the prevalence of HIV infection to no more
than 100 per 100,000.

"(44) Reduce gonorrhea to an incidence of no more than
225 cases per 100,000.

"(45) Reduce chlamydia trachomatis infections, as meas-
ured by a decrease in the incidence of nongonococcal urethritis
to no more than 170 cases per 100,000.

"(46) Reduce primary and secondary syphilis to an
incidence of no more than 10 cases per 100,000.

"(47) Reduce the incidence of pelvic inflammatory disease,
as measured by a reduction in hospitalization for pelvic inflam-
matory disease to no more than 250 per 100,000 women aged
15 through 44.

"(48) Reduce viral hepatitis B infection to no more than
40 per 100,000 cases.

"(49) Reduce indigenous cases of vaccine-preventable dis-
eases as follows:

"(A) Diphtheria among individuals aged 25 and

younger, 0.

"(B) Tetanus among individuals aged 25 and younger,

0.

"(C) Polio (wild-type virus), 0.
"(D) Measles, 0.